Janelle Laskowski

547 total citations · 1 hit paper
7 papers, 381 citations indexed

About

Janelle Laskowski is a scholar working on Epidemiology, Genetics and Gastroenterology. According to data from OpenAlex, Janelle Laskowski has authored 7 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Genetics and 4 papers in Gastroenterology. Recurrent topics in Janelle Laskowski's work include Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and Celiac Disease Research and Management (4 papers). Janelle Laskowski is often cited by papers focused on Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and Celiac Disease Research and Management (4 papers). Janelle Laskowski collaborates with scholars based in United States, United Kingdom and Japan. Janelle Laskowski's co-authors include Geert D’Haens, William J. Sandborn, Marc Ferrante, Jay Tuttle, Brian G. Feagan, Elina Berliba, Bal Raj Bhandari, Stuart Friedrich, M. Durante and Toshifumi Hibi∥ and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Annals of Epidemiology.

In The Last Decade

Janelle Laskowski

7 papers receiving 371 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

2023 170 citations Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine profile →

Peers

Janelle Laskowski

GENET

EPIDE

IMMUN

SURGE

GASTR

Timothy E. Ritter United States

Anthony Croft Australia

Gert A. Van Assche Belgium

Veerle J. Nuij Netherlands

Ivan Ferkolj Slovenia

B G Feagan Canada

B E Sands United States

D. J. Buurman Netherlands

Alexandre Aubourg France

J. García‐Paredes Spain

Timothy E. Ritter United States

Janelle Laskowski

279 ×0.9

GENET

215 ×1.0

EPIDE

89 ×0.7

IMMUN

110 ×1.4

SURGE

41 ×1.1

GASTR

Citations per year, relative to Janelle Laskowski Janelle Laskowski (= 1×) peers Timothy E. Ritter

Countries citing papers authored by Janelle Laskowski

Since Specialization

Citations

This map shows the geographic impact of Janelle Laskowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janelle Laskowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janelle Laskowski more than expected).

Fields of papers citing papers by Janelle Laskowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janelle Laskowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janelle Laskowski. The network helps show where Janelle Laskowski may publish in the future.

Co-authorship network of co-authors of Janelle Laskowski

This figure shows the co-authorship network connecting the top 25 collaborators of Janelle Laskowski. A scholar is included among the top collaborators of Janelle Laskowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janelle Laskowski. Janelle Laskowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

D’Haens, Geert, Marla C. Dubinsky, Taku Kobayashi, et al.. (2023). Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine. 388(26). 2444–2455. 170 indexed citations breakdown →

2.

Dubinsky, Marla C., Peter M. Irving, Xingyuan Li, et al.. (2023). P72 Efficacy and safety of mirikizumab as maintenance therapy in patients with moderate-severe active ulcerative colitis: phase 3 LUCENT-2 study results. Poster presentations. A86–A87. 1 indexed citations

3.

Dubinsky, Marla C., Peter M. Irving, Xingyuan Li, et al.. (2022). 867e: EFFICACY AND SAFETY OF MIRIKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 LUCENT-2 STUDY. Gastroenterology. 162(7). S–1393. 7 indexed citations

4.

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2019). Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis. Gastroenterology. 158(3). 537–549.e10. 179 indexed citations

5.

Sandborn, William J., Marc Ferrante, Raj Bhandari, et al.. (2019). P033 EFFICACY OF MIRIKIZUMAB ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY. Gastroenterology. 156(3). S23–S23. 1 indexed citations

6.

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2018). 882 - Efficacy and Safety of Anti-Interleukin-23 Therapy with Mirikizumab (LY3074828) in Patients with Moderate-To-Severe Ulcerative Colitis in a Phase 2 Study. Gastroenterology. 154(6). S–1360. 18 indexed citations

7.

Laskowski, Janelle, et al.. (2000). Job exposures as correlates of recovery in population-based rehabilitation intervention for work-related low back disorders. Annals of Epidemiology. 10(7). 481–481. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact